416 related articles for article (PubMed ID: 25234344)
1. Everyday life consequences of substance use in adult patients with a substance use disorder (SUD) and co-occurring attention deficit/hyperactivity disorder (ADHD) or autism spectrum disorder (ASD): a patient's perspective.
Kronenberg LM; Slager-Visscher K; Goossens PJ; van den Brink W; van Achterberg T
BMC Psychiatry; 2014 Sep; 14():264. PubMed ID: 25234344
[TBL] [Abstract][Full Text] [Related]
2. Need for care and life satisfaction in adult substance use disorder patients with and without attention deficit hyperactivity disorder (ADHD) or autism spectrum disorder (ASD).
Kronenberg LM; Goossens PJ; van Etten DM; van Achterberg T; van den Brink W
Perspect Psychiatr Care; 2015 Jan; 51(1):4-15. PubMed ID: 24410895
[TBL] [Abstract][Full Text] [Related]
3. Coping styles in substance use disorder (SUD) patients with and without co-occurring attention deficit/hyperactivity disorder (ADHD) or autism spectrum disorder (ASD).
Kronenberg LM; Goossens PJ; van Busschbach J; van Achterberg T; van den Brink W
BMC Psychiatry; 2015 Jul; 15():159. PubMed ID: 26169586
[TBL] [Abstract][Full Text] [Related]
4. Treatment seeking adults with autism or ADHD and co-morbid substance use disorder: prevalence, risk factors and functional disability.
Sizoo B; van den Brink W; Koeter M; Gorissen van Eenige M; van Wijngaarden-Cremers P; van der Gaag RJ
Drug Alcohol Depend; 2010 Feb; 107(1):44-50. PubMed ID: 19786328
[TBL] [Abstract][Full Text] [Related]
5. Personal recovery in individuals diagnosed with substance use disorder (SUD) and co-occurring attention deficit/hyperactivity disorder (ADHD) or autism spectrum disorder (ASD).
Kronenberg LM; Verkerk-Tamminga R; Goossens PJ; van den Brink W; van Achterberg T
Arch Psychiatr Nurs; 2015 Aug; 29(4):242-8. PubMed ID: 26165980
[TBL] [Abstract][Full Text] [Related]
6. Decreased risk for substance use disorders in individuals with high-functioning autism spectrum disorder.
Yule AM; DiSalvo M; Biederman J; Wilens TE; Dallenbach NT; Taubin D; Joshi G
Eur Child Adolesc Psychiatry; 2023 Feb; 32(2):257-265. PubMed ID: 34363537
[TBL] [Abstract][Full Text] [Related]
7. The complicated relationship between attention deficit/hyperactivity disorder and substance use disorders.
Zulauf CA; Sprich SE; Safren SA; Wilens TE
Curr Psychiatry Rep; 2014 Mar; 16(3):436. PubMed ID: 24526271
[TBL] [Abstract][Full Text] [Related]
8. [ADHD in Adults and Comorbid Substance Use Disorder: Prevalence, Clinical Diagnostics and Integrated Therapy].
Dirks H; Scherbaum N; Kis B; Mette C
Fortschr Neurol Psychiatr; 2017 Jun; 85(6):336-344. PubMed ID: 28645126
[TBL] [Abstract][Full Text] [Related]
9. Attention deficit/hyperactivity disorders with co-existing substance use disorder is characterized by early antisocial behaviour and poor cognitive skills.
Bihlar Muld B; Jokinen J; Bölte S; Hirvikoski T
BMC Psychiatry; 2013 Dec; 13():336. PubMed ID: 24330331
[TBL] [Abstract][Full Text] [Related]
10. Lifetime co-occurring psychiatric disorders in newly diagnosed adults with attention deficit hyperactivity disorder (ADHD) or/and autism spectrum disorder (ASD).
Pehlivanidis A; Papanikolaou K; Mantas V; Kalantzi E; Korobili K; Xenaki LA; Vassiliou G; Papageorgiou C
BMC Psychiatry; 2020 Aug; 20(1):423. PubMed ID: 32847520
[TBL] [Abstract][Full Text] [Related]
11. Critical exploration of co-occurring Attention-Deficit/Hyperactivity Disorder, mood disorder and Substance Use Disorder.
Regnart J; Truter I; Meyer A
Expert Rev Pharmacoecon Outcomes Res; 2017 Jun; 17(3):275-282. PubMed ID: 28686107
[TBL] [Abstract][Full Text] [Related]
12. Integrated cognitive behavioral therapy for ADHD in adult substance use disorder patients: Results of a randomized clinical trial.
van Emmerik-van Oortmerssen K; Vedel E; Kramer FJ; Blankers M; Dekker JJM; van den Brink W; Schoevers RA
Drug Alcohol Depend; 2019 Apr; 197():28-36. PubMed ID: 30769263
[TBL] [Abstract][Full Text] [Related]
13. Personality characteristics of adults with autism spectrum disorders or attention deficit hyperactivity disorder with and without substance use disorders.
Sizoo B; van den Brink W; Gorissen van Eenige M; van der Gaag RJ
J Nerv Ment Dis; 2009 Jun; 197(6):450-4. PubMed ID: 19525746
[TBL] [Abstract][Full Text] [Related]
14. Do candidate genes discriminate patients with an autism spectrum disorder from those with attention deficit/hyperactivity disorder and is there an effect of lifetime substance use disorders?
Sizoo B; van den Brink W; Franke B; Vasquez AA; van Wijngaarden-Cremers P; van der Gaag RJ
World J Biol Psychiatry; 2010 Aug; 11(5):699-708. PubMed ID: 20446882
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and characteristics of South African treatment-seeking patients with substance use disorder and co-occurring attention-deficit/hyperactivity disorder.
Coetzee C; Truter I; Meyer A
Expert Rev Clin Pharmacol; 2020 Nov; 13(11):1271-1280. PubMed ID: 33040639
[TBL] [Abstract][Full Text] [Related]
16. Risk behaviours among substance use disorder treatment seekers with and without adult ADHD symptoms.
Kaye S; Gilsenan J; Young JT; Carruthers S; Allsop S; Degenhardt L; van de Glind G; van den Brink W
Drug Alcohol Depend; 2014 Nov; 144():70-7. PubMed ID: 25193717
[TBL] [Abstract][Full Text] [Related]
17. [International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder].
Özgen H; Spijkerman R; Noack M; Holtmann M; Schellekens ASA; van de Glind G; Banaschewski T; Barta C; Begeman A; Casas M; Crunelle CL; Daigre Blanco C; Dalsgaard S; Demetrovics Z; den Boer J; Dom G; Eapen V; Faraone SV; Franck J; González RA; Grau-López L; Groenman AP; Hemphälä M; Icick R; Johnson B; Kaess M; Kapitány-Fövény M; Kasinathan JG; Kaye SS; Kiefer F; Konstenius M; Levin FR; Luderer M; Martinotti G; Matthys FIA; Meszaros G; Moggi F; Munasur-Naidoo AP; Post M; Rabinovitz S; Ramos-Quiroga JA; Sala R; Shafi A; Slobodin O; Staal WG; Thomasius R; Truter I; van Kernebeek MW; Velez-Pastrana MC; Vollstädt-Klein S; Vorspan F; Young JT; Yule A; van den Brink W; Hendriks V
Z Kinder Jugendpsychiatr Psychother; 2021 Jan; 50(1):54-67. PubMed ID: 34397296
[TBL] [Abstract][Full Text] [Related]
18. Psychiatric comorbidity in treatment-seeking substance use disorder patients with and without attention deficit hyperactivity disorder: results of the IASP study.
van Emmerik-van Oortmerssen K; van de Glind G; Koeter MW; Allsop S; Auriacombe M; Barta C; Bu ET; Burren Y; Carpentier PJ; Carruthers S; Casas M; Demetrovics Z; Dom G; Faraone SV; Fatseas M; Franck J; Johnson B; Kapitány-Fövény M; Kaye S; Konstenius M; Levin FR; Moggi F; Møller M; Ramos-Quiroga JA; Schillinger A; Skutle A; Verspreet S; ; van den Brink W; Schoevers RA
Addiction; 2014 Feb; 109(2):262-72. PubMed ID: 24118292
[TBL] [Abstract][Full Text] [Related]
19. Quality of life in substance use disorder patients with and without attention deficit hyperactivity disorder 12 months after treatment: a naturalistic follow-up study.
Flores-García L; Lensing MB; Ytterstad E; Eisemann M
Atten Defic Hyperact Disord; 2019 Sep; 11(3):299-310. PubMed ID: 30903585
[TBL] [Abstract][Full Text] [Related]
20. Difficulties in everyday life: young persons with attention-deficit/hyperactivity disorder and autism spectrum disorders perspectives. A chat-log analysis.
Ahlström BH; Wentz E
Int J Qual Stud Health Well-being; 2014; 9():23376. PubMed ID: 24875238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
